Chaim Sheba medical center, Oncology division

Ramat Gan 5262000

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Prostate Cancer, Renal Cell Carcinoma

Studies at this site

• Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer — Completed
• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early